Wellington Management Group
TCRT icon

Wellington Management Group’s Alaunos Therapeutics TCRT Stock Holding History

Wellington Management Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,041
Closed -$824K – 2218
2021
Q4 		$824K Buy
+5,041
New +$1.11M ﹤0.01% 1834
2016
Q4 		– Sell
-1,980
Closed -$1.67M – 2267
2016
Q3 		$1.67M Sell
1,980
-556
-22% -$447K ﹤0.01% 1692
2016
Q2 		$2.09M Sell
2,536
-435
-15% -$474K ﹤0.01% 1591
2016
Q1 		$3.31M Buy
2,971
+487
+20% +$498K ﹤0.01% 1462
2015
Q4 		$3.1M Buy
+2,484
New +$4.11M ﹤0.01% 1501

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wellington Management Group's TCRT Position: Q1 2022 in Review

Wellington Management Group sold out of Alaunos Therapeutics (TCRT) in Q1 2022, closing a stake of 5,041 shares — an estimated $824K sold.

Wellington Management Group first reported a position in TCRT in Q4 2015 and held it in 5 quarters. The position peaked at $3.31M in Q1 2016. 148 funds tracked by Wall St. Rank hold TCRT as of Q1 2022.

  • Wellington Management Group reported no remaining Alaunos Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Wellington Management Group sold 5,041 Alaunos Therapeutics shares in Q1 2022, an estimated $824K.
  • Wellington Management Group first reported a position in Alaunos Therapeutics in Q4 2015 and held it in 5 quarters.
  • Wellington Management Group's Alaunos Therapeutics position peaked at $3.31M in Q1 2016.
  • 148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2022.

Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.